This is a Question and Answer follow up for the webinar, Telemedicine: Getting Started, Regulations and Privacy Issues. This meeting is hosted by American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant. (No CME offered for this course.)

The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 enacted by Congress on March 6, 2020. As a result, this would allow broader use of and payment for telehealth services for Medicare beneficiaries during the emergency period as defined under the legislation. Also due to the COVID-19 national public health emergency, as of March 16, 2020, and continuing for as long as the designation of a public health emergency remains, DEA-registered practitioners may issues prescriptions for schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation providing certain other conditions are met. Furthermore, restrictions on where telemedicine may be practiced have been suspended. These recent emergency changes in telemedicine regulations open new opportunities in the assessment and treatment of opioid use disorder during these turbulent times.

This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will discuss changes in regulations, present ways to incorporate telemedicine into your current practice of treating OUD in the time of social distancing and stay at home orders, and discuss how to get reimbursed for this service.

Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Recorded 4/8/2020 (No CME offered for this course.)